Trial
NCT03919292
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Virginia Commonwealth University
Collaborators
Puma Biotechnology, Inc.
Condition
Solid Tumor, Adult
Intervention
Neratinib
Why stopped
Pending amendment approval
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-29